Piramal Pharma shares fall 3% after USFDA issues 7 observations at UK facility

The USFDA issued a Form 483 following a Good Manufacturing Practices (GMP) inspection of the facility, Piramal Pharma said in a stock exchange filing on Monday.

Leave a Reply

Your email address will not be published. Required fields are marked *